 | • レポートコード：QYR9ST09753 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、ダクラタスビルの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、30mg、60mgに、用途別には、C型肝炎ウイルス（HCV）遺伝子型1、C型肝炎ウイルス（HCV）遺伝子型3、C型肝炎ウイルス（HCV）遺伝子型4にセグメント区分し、ダクラタスビルの世界市場を分析しました。 ・エグゼクティブ・サマリー ・ダクラタスビルの世界市場概要 ・ダクラタスビルの製造コスト構成分析 ・ダクラタスビルの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ダクラタスビルの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ダクラタスビルのセグメント分析（種類別） （30mg、60mg） ・ダクラタスビルのセグメント分析（用途別） （C型肝炎ウイルス（HCV）遺伝子型1、C型肝炎ウイルス（HCV）遺伝子型3、C型肝炎ウイルス（HCV）遺伝子型4） ・ダクラタスビルの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Bristol-Myers Squibb、Natco Pharma、Zydus Cadila、Hetero Drugs、Dr Reddy's Laboratories、Cipla、Mylan、Abbott、Emcure Pharmaceuticals、Torrent Pharmaceuticals、Biocon） ・ダクラタスビルの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Daclatasvir market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Daclatasvir volume and value at global level, regional level and company level. From a global perspective, this report represents overall Daclatasvir market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Daclatasvir in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Daclatasvir manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Bristol-Myers Squibb
Natco Pharma
Zydus Cadila
Hetero Drugs
Dr Reddy’s Laboratories
Cipla
Mylan
Abbott
Emcure Pharmaceuticals
Torrent Pharmaceuticals
Biocon
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
30mg Tables
60mg Tables
Segment by Application
Hepatitis C Virus (HCV) Genotype 1
Hepatitis C Virus (HCV) Genotype 3
Hepatitis C Virus (HCV) Genotype 4
Table of Contents
Executive Summary
1 Industry Overview of Daclatasvir
1.1 Definition of Daclatasvir
1.2 Daclatasvir Segment by Type
1.2.1 Global Daclatasvir Production Growth Rate Comparison by Types (2014-2025)
1.2.2 30mg Tables
1.2.3 60mg Tables
1.3 Daclatasvir Segment by Applications
1.3.1 Global Daclatasvir Consumption Comparison by Applications (2014-2025)
1.3.2 Hepatitis C Virus (HCV) Genotype 1
1.3.3 Hepatitis C Virus (HCV) Genotype 3
1.3.4 Hepatitis C Virus (HCV) Genotype 4
1.4 Global Daclatasvir Overall Market
1.4.1 Global Daclatasvir Revenue (2014-2025)
1.4.2 Global Daclatasvir Production (2014-2025)
1.4.3 North America Daclatasvir Status and Prospect (2014-2025)
1.4.4 Europe Daclatasvir Status and Prospect (2014-2025)
1.4.5 China Daclatasvir Status and Prospect (2014-2025)
1.4.6 Japan Daclatasvir Status and Prospect (2014-2025)
1.4.7 Southeast Asia Daclatasvir Status and Prospect (2014-2025)
1.4.8 India Daclatasvir Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Daclatasvir
2.3 Manufacturing Process Analysis of Daclatasvir
2.4 Industry Chain Structure of Daclatasvir
3 Development and Manufacturing Plants Analysis of Daclatasvir
3.1 Capacity and Commercial Production Date
3.2 Global Daclatasvir Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Daclatasvir
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Daclatasvir Production and Capacity Analysis
4.2 Daclatasvir Revenue Analysis
4.3 Daclatasvir Price Analysis
4.4 Market Concentration Degree
5 Daclatasvir Regional Market Analysis
5.1 Daclatasvir Production by Regions
5.1.1 Global Daclatasvir Production by Regions
5.1.2 Global Daclatasvir Revenue by Regions
5.2 Daclatasvir Consumption by Regions
5.3 North America Daclatasvir Market Analysis
5.3.1 North America Daclatasvir Production
5.3.2 North America Daclatasvir Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Daclatasvir Import and Export
5.4 Europe Daclatasvir Market Analysis
5.4.1 Europe Daclatasvir Production
5.4.2 Europe Daclatasvir Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Daclatasvir Import and Export
5.5 China Daclatasvir Market Analysis
5.5.1 China Daclatasvir Production
5.5.2 China Daclatasvir Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Daclatasvir Import and Export
5.6 Japan Daclatasvir Market Analysis
5.6.1 Japan Daclatasvir Production
5.6.2 Japan Daclatasvir Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Daclatasvir Import and Export
5.7 Southeast Asia Daclatasvir Market Analysis
5.7.1 Southeast Asia Daclatasvir Production
5.7.2 Southeast Asia Daclatasvir Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Daclatasvir Import and Export
5.8 India Daclatasvir Market Analysis
5.8.1 India Daclatasvir Production
5.8.2 India Daclatasvir Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Daclatasvir Import and Export
6 Daclatasvir Segment Market Analysis (by Type)
6.1 Global Daclatasvir Production by Type
6.2 Global Daclatasvir Revenue by Type
6.3 Daclatasvir Price by Type
7 Daclatasvir Segment Market Analysis (by Application)
7.1 Global Daclatasvir Consumption by Application
7.2 Global Daclatasvir Consumption Market Share by Application (2014-2019)
8 Daclatasvir Major Manufacturers Analysis
8.1 Bristol-Myers Squibb
8.1.1 Bristol-Myers Squibb Daclatasvir Production Sites and Area Served
8.1.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.1.3 Bristol-Myers Squibb Daclatasvir Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Natco Pharma
8.2.1 Natco Pharma Daclatasvir Production Sites and Area Served
8.2.2 Natco Pharma Product Introduction, Application and Specification
8.2.3 Natco Pharma Daclatasvir Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Zydus Cadila
8.3.1 Zydus Cadila Daclatasvir Production Sites and Area Served
8.3.2 Zydus Cadila Product Introduction, Application and Specification
8.3.3 Zydus Cadila Daclatasvir Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Hetero Drugs
8.4.1 Hetero Drugs Daclatasvir Production Sites and Area Served
8.4.2 Hetero Drugs Product Introduction, Application and Specification
8.4.3 Hetero Drugs Daclatasvir Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Dr Reddy’s Laboratories
8.5.1 Dr Reddy’s Laboratories Daclatasvir Production Sites and Area Served
8.5.2 Dr Reddy’s Laboratories Product Introduction, Application and Specification
8.5.3 Dr Reddy’s Laboratories Daclatasvir Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Cipla
8.6.1 Cipla Daclatasvir Production Sites and Area Served
8.6.2 Cipla Product Introduction, Application and Specification
8.6.3 Cipla Daclatasvir Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Mylan
8.7.1 Mylan Daclatasvir Production Sites and Area Served
8.7.2 Mylan Product Introduction, Application and Specification
8.7.3 Mylan Daclatasvir Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Abbott
8.8.1 Abbott Daclatasvir Production Sites and Area Served
8.8.2 Abbott Product Introduction, Application and Specification
8.8.3 Abbott Daclatasvir Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Emcure Pharmaceuticals
8.9.1 Emcure Pharmaceuticals Daclatasvir Production Sites and Area Served
8.9.2 Emcure Pharmaceuticals Product Introduction, Application and Specification
8.9.3 Emcure Pharmaceuticals Daclatasvir Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Torrent Pharmaceuticals
8.10.1 Torrent Pharmaceuticals Daclatasvir Production Sites and Area Served
8.10.2 Torrent Pharmaceuticals Product Introduction, Application and Specification
8.10.3 Torrent Pharmaceuticals Daclatasvir Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Biocon
9 Development Trend of Analysis of Daclatasvir Market
9.1 Global Daclatasvir Market Trend Analysis
9.1.1 Global Daclatasvir Market Size (Volume and Value) Forecast 2019-2025
9.2 Daclatasvir Regional Market Trend
9.2.1 North America Daclatasvir Forecast 2019-2025
9.2.2 Europe Daclatasvir Forecast 2019-2025
9.2.3 China Daclatasvir Forecast 2019-2025
9.2.4 Japan Daclatasvir Forecast 2019-2025
9.2.5 Southeast Asia Daclatasvir Forecast 2019-2025
9.2.6 India Daclatasvir Forecast 2019-2025
9.3 Daclatasvir Market Trend (Product Type)
9.4 Daclatasvir Market Trend (Application)
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Daclatasvir Distributors List
10.3 Daclatasvir Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Daclatasvir
Table Global Daclatasvir Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Daclatasvir Production Market Share by Types in 2018
Figure 30mg Tables Product Picture
Figure 60mg Tables Product Picture
Table Global Daclatasvir Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Daclatasvir Consumption Market Share by Applications in 2018
Figure Hepatitis C Virus (HCV) Genotype 1
Figure Hepatitis C Virus (HCV) Genotype 3
Figure Hepatitis C Virus (HCV) Genotype 4
Figure Global Daclatasvir Revenue (Million USD) (2014-2025)
Figure Global Daclatasvir Production (K Pcs) (2014-2025)
Figure North America Daclatasvir Market Size (Million USD) (2014-2025)
Figure Europe Daclatasvir Market Size (Million USD) (2014-2025)
Figure China Daclatasvir Market Size (Million USD) (2014-2025)
Figure Japan Daclatasvir Market Size (Million USD) (2014-2025)
Figure Southeast Asia Daclatasvir Market Size (Million USD) (2014-2025)
Figure India Daclatasvir Market Size (Million USD) (2014-2025)
Table Daclatasvir Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Daclatasvir in 2018
Figure Manufacturing Process Analysis of Daclatasvir
Figure Industry Chain Structure of Daclatasvir
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Daclatasvir Manufacturing Plants Distribution
Table Daclatasvir Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Daclatasvir Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Daclatasvir Production (K Pcs) of Major Manufacturers (2014-2019)
Table Daclatasvir Production Market Share of Major Manufacturers (2014-2019)
Figure Daclatasvir Production Share by Manufacturers in 2018
Table Daclatasvir Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Daclatasvir Revenue Market Share of Major Manufacturers (2014-2019)
Figure Daclatasvir Revenue Share by Manufacturers in 2018
Table Daclatasvir Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Daclatasvir Production by Regions 2014-2019 (K Pcs)
Table Global Daclatasvir Production Market Share by Regions 2014-2019
Figure Global Daclatasvir Production Market Share by Regions in 2018
Table Global Daclatasvir Revenue by Regions 2014-2019 (Million USD)
Table Global Daclatasvir Revenue Market Share by Regions 2014-2019
Figure Global Daclatasvir Revenue Market Share by Regions in 2018
Table Global Daclatasvir Consumption by Regions 2014-2019 (K Pcs)
Table Global Daclatasvir Consumption Market Share by Regions 2014-2019
Figure North America Daclatasvir Production Growth Rate 2014-2019 (K Pcs)
Figure North America Daclatasvir Revenue Growth Rate 2014-2019 (Million USD)
Table North America Daclatasvir Production, Consumption Import and Export (K Pcs)
Figure Europe Daclatasvir Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Daclatasvir Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Daclatasvir Production, Consumption Import and Export (K Pcs)
Figure China Daclatasvir Production Growth Rate 2014-2019 (K Pcs)
Figure China Daclatasvir Revenue Growth Rate 2014-2019 (Million USD)
Table China Daclatasvir Production, Consumption Import and Export (K Pcs)
Figure Japan Daclatasvir Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Daclatasvir Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Daclatasvir Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Daclatasvir Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Daclatasvir Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Daclatasvir Production, Consumption Import and Export (K Pcs)
Figure India Daclatasvir Production Growth Rate 2014-2019 (K Pcs)
Figure India Daclatasvir Revenue Growth Rate 2014-2019 (Million USD)
Table India Daclatasvir Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Daclatasvir Market Share by Application (2014-2019)
Figure Global Value (Consumption) Daclatasvir Market Share by Application (2014-2019)
Table Bristol-Myers Squibb Daclatasvir Production Sites and Area Served
Table Bristol-Myers Squibb Daclatasvir Product Introduction, Application and Specification
Table Bristol-Myers Squibb Daclatasvir Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Daclatasvir Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Daclatasvir Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Daclatasvir Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Daclatasvir Main Business and Markets Served
Table Natco Pharma Daclatasvir Production Sites and Area Served
Table Natco Pharma Daclatasvir Product Introduction, Application and Specification
Table Natco Pharma Daclatasvir Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Natco Pharma Daclatasvir Production Growth Rate (2014-2019)
Table Natco Pharma Daclatasvir Production Market Share (2014-2019)
Figure Natco Pharma Daclatasvir Revenue Market Share (2014-2019)
Table Natco Pharma Daclatasvir Main Business and Markets Served
Table Zydus Cadila Daclatasvir Production Sites and Area Served
Table Zydus Cadila Daclatasvir Product Introduction, Application and Specification
Table Zydus Cadila Daclatasvir Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Zydus Cadila Daclatasvir Production Growth Rate (2014-2019)
Table Zydus Cadila Daclatasvir Production Market Share (2014-2019)
Figure Zydus Cadila Daclatasvir Revenue Market Share (2014-2019)
Table Zydus Cadila Daclatasvir Main Business and Markets Served
Table Hetero Drugs Daclatasvir Production Sites and Area Served
Table Hetero Drugs Daclatasvir Product Introduction, Application and Specification
Table Hetero Drugs Daclatasvir Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Hetero Drugs Daclatasvir Production Growth Rate (2014-2019)
Table Hetero Drugs Daclatasvir Production Market Share (2014-2019)
Figure Hetero Drugs Daclatasvir Revenue Market Share (2014-2019)
Table Hetero Drugs Daclatasvir Main Business and Markets Served
Table Dr Reddy's Laboratories Daclatasvir Production Sites and Area Served
Table Dr Reddy's Laboratories Daclatasvir Product Introduction, Application and Specification
Table Dr Reddy's Laboratories Daclatasvir Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Dr Reddy's Laboratories Daclatasvir Production Growth Rate (2014-2019)
Table Dr Reddy's Laboratories Daclatasvir Production Market Share (2014-2019)
Figure Dr Reddy's Laboratories Daclatasvir Revenue Market Share (2014-2019)
Table Dr Reddy's Laboratories Daclatasvir Main Business and Markets Served
Table Cipla Daclatasvir Production Sites and Area Served
Table Cipla Daclatasvir Product Introduction, Application and Specification
Table Cipla Daclatasvir Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cipla Daclatasvir Production Growth Rate (2014-2019)
Table Cipla Daclatasvir Production Market Share (2014-2019)
Figure Cipla Daclatasvir Revenue Market Share (2014-2019)
Table Cipla Daclatasvir Main Business and Markets Served
Table Mylan Daclatasvir Production Sites and Area Served
Table Mylan Daclatasvir Product Introduction, Application and Specification
Table Mylan Daclatasvir Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Mylan Daclatasvir Production Growth Rate (2014-2019)
Table Mylan Daclatasvir Production Market Share (2014-2019)
Figure Mylan Daclatasvir Revenue Market Share (2014-2019)
Table Mylan Daclatasvir Main Business and Markets Served
Table Abbott Daclatasvir Production Sites and Area Served
Table Abbott Daclatasvir Product Introduction, Application and Specification
Table Abbott Daclatasvir Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Abbott Daclatasvir Production Growth Rate (2014-2019)
Table Abbott Daclatasvir Production Market Share (2014-2019)
Figure Abbott Daclatasvir Revenue Market Share (2014-2019)
Table Abbott Daclatasvir Main Business and Markets Served
Table Emcure Pharmaceuticals Daclatasvir Production Sites and Area Served
Table Emcure Pharmaceuticals Daclatasvir Product Introduction, Application and Specification
Table Emcure Pharmaceuticals Daclatasvir Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Emcure Pharmaceuticals Daclatasvir Production Growth Rate (2014-2019)
Table Emcure Pharmaceuticals Daclatasvir Production Market Share (2014-2019)
Figure Emcure Pharmaceuticals Daclatasvir Revenue Market Share (2014-2019)
Table Emcure Pharmaceuticals Daclatasvir Main Business and Markets Served
Table Torrent Pharmaceuticals Daclatasvir Production Sites and Area Served
Table Torrent Pharmaceuticals Daclatasvir Product Introduction, Application and Specification
Table Torrent Pharmaceuticals Daclatasvir Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Torrent Pharmaceuticals Daclatasvir Production Growth Rate (2014-2019)
Table Torrent Pharmaceuticals Daclatasvir Production Market Share (2014-2019)
Figure Torrent Pharmaceuticals Daclatasvir Revenue Market Share (2014-2019)
Table Torrent Pharmaceuticals Daclatasvir Main Business and Markets Served
Table Biocon Daclatasvir Production Sites and Area Served
Figure Global Daclatasvir Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Daclatasvir Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Daclatasvir Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Daclatasvir Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Daclatasvir Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Daclatasvir Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Daclatasvir Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Daclatasvir Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Daclatasvir Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Daclatasvir Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Daclatasvir Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Daclatasvir Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Daclatasvir Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Daclatasvir Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Daclatasvir Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Daclatasvir by Type (2019-2025)
Table Global Consumption (K Pcs) of Daclatasvir by Application (2019-2025)
Table Daclatasvir Distributors List
Table Daclatasvir Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
C型肝炎ウイルス及び治療薬の世界市場：市場規模・現状・予測 Hepatitis C virus (HCV) is the leading cause of end-stage liver disease and hepatocellular carcinoma. Hepatitis C virus (HCV) is the leading cause of end-stage liver disease and hepatocellular carcinomaIn 2018, the global Hepatitis C Virus And Therapeutics market size was xx million US$ and it is ex…- C型肝炎ウイルス（HCV）の世界市場：市場規模・現状・予測 Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chro…
- 世界のソホスブビル/レディパスビル複合薬市場：専門的調査 The global Sofosbuvir/Ledipasvir Compound Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Sofosbuvir/Ledipasvir Compound Drugs volume and value at global level, regional level and co…
- 腫瘍溶解性ウイルス免疫療法の世界市場：市場規模・現状・予測 Oncology Immunotherapy exploits virus's ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus …
- おたふく風邪ウイルス検査の世界市場：市場規模・現状・予測 Mumps is a contagious disease which affects children as well as adult and it is caused by the mumps virus. Mumps is a type of viral infection that affects the parotid gland which one of the member of saliva producing gland. The swelling in one or both parotid gland is the indication for the mumps. T…